257 related articles for article (PubMed ID: 20863342)
1. Zoster vaccine in older adults.
Fried R
J Am Geriatr Soc; 2010 Sep; 58(9):1799-800. PubMed ID: 20863342
[No Abstract] [Full Text] [Related]
2. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM; Brisson M; Levin MJ
Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
[TBL] [Abstract][Full Text] [Related]
3. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
[TBL] [Abstract][Full Text] [Related]
4. [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia].
MMW Fortschr Med; 2006; Spec no.1():14-5. PubMed ID: 16872127
[No Abstract] [Full Text] [Related]
5. [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications].
Marino MG; Bagnato B; Torella I; Franco E
Ig Sanita Pubbl; 2009; 65(3):299-311. PubMed ID: 19629155
[TBL] [Abstract][Full Text] [Related]
6. Varicella zoster virus redux.
Gelb LD
Herpes; 2009 Jan; 15(3):62-3. PubMed ID: 19306605
[TBL] [Abstract][Full Text] [Related]
7. Herpes zoster vaccine brings relief for the elderly.
Morrow T
Manag Care; 2006 Dec; 15(12):57-8. PubMed ID: 17260848
[No Abstract] [Full Text] [Related]
8. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
9. Prevention of herpes zoster and its painful and debilitating complications.
Johnson R; McElhaney J; Pedalino B; Levin M
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
[TBL] [Abstract][Full Text] [Related]
10. Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination.
Gelb LD
J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S18-21. PubMed ID: 19553631
[TBL] [Abstract][Full Text] [Related]
11. [Zoster vaccine].
Wutzler P
Klin Monbl Augenheilkd; 2010 May; 227(5):384-7. PubMed ID: 20490991
[TBL] [Abstract][Full Text] [Related]
12. Q: Who should receive the shingles vaccine?
Singh A; Englund K
Cleve Clin J Med; 2009 Jan; 76(1):45-8. PubMed ID: 19122110
[No Abstract] [Full Text] [Related]
13. Zoster vaccine: current status and future prospects.
Oxman MN
Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium.
Bilcke J; Marais C; Ogunjimi B; Willem L; Hens N; Beutels P
Vaccine; 2012 Jan; 30(3):675-84. PubMed ID: 22120193
[TBL] [Abstract][Full Text] [Related]
15. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
Holcomb K; Weinberg JM
J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
[TBL] [Abstract][Full Text] [Related]
16. Taking a shot at shingles.
Johns Hopkins Med Lett Health After 50; 2012 Aug; 24(7):8. PubMed ID: 23033561
[No Abstract] [Full Text] [Related]
17. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
Lu PJ; Euler GL; Jumaan AO; Harpaz R
Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
[TBL] [Abstract][Full Text] [Related]
18. Herpes zoster in older adults.
Cadogan MP
J Gerontol Nurs; 2010 Mar; 36(3):10-4. PubMed ID: 20302254
[TBL] [Abstract][Full Text] [Related]
19. Herpes zoster vaccination: benefits and barriers.
Komara FA
J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S22-4. PubMed ID: 19553633
[TBL] [Abstract][Full Text] [Related]
20. Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(44):1528. PubMed ID: 22071592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
